UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032137
Receipt number R000036606
Scientific Title The investigation of the withdrawal movement associated with the injection of the generic rocuronium formulation in children
Date of disclosure of the study information 2018/04/09
Last modified on 2021/10/25 21:57:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The investigation of the withdrawal movement associated with the injection of the generic rocuronium formulation in children

Acronym

The investigation of the withdrawal movement associated with the injection of the generic rocuronium formulation in children

Scientific Title

The investigation of the withdrawal movement associated with the injection of the generic rocuronium formulation in children

Scientific Title:Acronym

The investigation of the withdrawal movement associated with the injection of the generic rocuronium formulation in children

Region

Japan


Condition

Condition

Pediatric patients who are American Society of Anesthesiologists physical status 1 or 2, aged from 2 months to 11 years, and undergoing general anesthesia for scheduled oral surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Eslax has been reported to cause withdrawal movements (injected wrist only, arm only with elbow and shoulder or generalized response or movement) associated with injection pain and its frequency is high in children. Although the generic rocuronium formulation is suggested to have reduced the injection pain in animal study, the clinical utility in children has not been reported yet. In this study, we compare the frequency of withdrawal movements caused by Eslax or generic rocuronium formulation in children.

Basic objectives2

Others

Basic objectives -Others

To verify the degree of side reaction

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Presence or absence of the withdrawal movement associated with the injection of rocuronium

Key secondary outcomes

Degree of the withdrawal movement associated with the injection of rocuronium

Changes in vital signs before and after administration of rocuronium


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Pediatric patients who are American Society of Anesthesiologists physical status 1 or 2,aged from 2 months to 11 years, and undergoing general anesthesia for scheduled oral surgery

Key exclusion criteria

1.Patients with history of cardiovascular,respiratory(asthma),liver, kidney,muscle,brain,neurologic disease
2.Obesity
3.Drug allergy
4.Patients who had received analgesics within the previous 24 hours
5.Upper respiratory infection
6.Difficulty securing venous route and difficulty of securing airway

Target sample size

160


Research contact person

Name of lead principal investigator

1st name Mika
Middle name
Last name Inoue

Organization

Osaka University Graduate School of Dentistry

Division name

Department of Dental Anesthesiology

Zip code

565-0871

Address

1-8,Yamadaoka,Suita,Osaka 565-0871,Japan

TEL

06-6879-2972

Email

mi.sweetbay@gmail.com


Public contact

Name of contact person

1st name Mika
Middle name
Last name noue

Organization

Osaka University Graduate School of Dentistry

Division name

Department of Dental Anesthesiology

Zip code

565-0871

Address

1-8,Yamadaoka,Suita,Osaka 565-0871,Japan

TEL

06-6879-2972

Homepage URL


Email

mi.sweetbay@gmail.com


Sponsor or person

Institute

Osaka University Graduate School of Dentistry

Institute

Department

Personal name



Funding Source

Organization

Osaka University Graduate School of Dentistry

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka University Graduate School of Dentistry

Address

1-8,Yamadaoka,Suita,Osaka 565-0871,Japan

Tel

06-6879-2831

Email

si-soumu-syomu@office.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学歯学部附属病院(大阪府)


Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 12 Month 18 Day

Date of IRB

2017 Year 12 Month 18 Day

Anticipated trial start date

2018 Year 04 Month 09 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observation items
1.Presence or absence of the withdrawal movement associated with the injection of rocuronium
2.Degree of the withdrawal movement associated with the injection of rocuronium
3.Changes in vital signs before and after administration of rocuronium


Management information

Registered date

2018 Year 04 Month 06 Day

Last modified on

2021 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036606


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name